undefined | CalcMoney

title: "S-1/A Files S-1: RSU & Capital Gains Tax Exposure Calculator — Aug 20, 2026" excerpt: "S-1/A - NON INVASIVE MONITORING SYSTEMS INC /FL/ (0000720762) (Filer)" date: "2026-08-20T10:24:58.843Z" coverImage: "/images/blog/market-briefing-ipo-filing-2026-08-20.png" triggerSource: "sec-ipo-filing" briefingType: "ipo-filing"

What Changed

Non Invasive Monitoring Systems filed an amended S-1 on August 20, 2026. The 28 MB filing size suggests substantial disclosure expansion, likely updated financials, risk factors, or valuation methodology ahead of pricing. For portfolios considering IPO allocation strategies, this filing represents the final pre-pricing disclosure window.

The Numbers That Matter

Metric	Pre-Amendment Baseline	Typical S-1/A Expansion	CalcMoney Reference Point
Filing size	8 MB to 12 MB (initial S-1 standard)	28 MB (233% over baseline)	Over 20 MB suggests material revision
Days to pricing post-amendment	14 to 21 days (median)	10 to 28 days (range)	Under 30 days is typical
IPO allocation illustrative range	$25K to $50K retail example	$100K to $500K qualified example	$250K represents meaningful position size
Lock-up period standard	90 to 180 days post-pricing	Varies by deal structure	Consult offering documents for specifics

The 28 MB file indicates extensive updates. Most amended S-1s in this size range include revised pro forma financials, expanded risk disclosures, or updated use-of-proceeds sections. Investors evaluating potential IPO allocations can use this window to assess underwriting assumptions before the roadshow concludes.

What This Means for Your Portfolio

Consider a hypothetical $500K allocation to this IPO, priced at a midpoint of a typical healthcare technology range ($12 to $18 per share). This creates $500K in illiquid exposure for 180 days post-pricing. The amended filing provides an opportunity to stress-test the revenue growth assumptions and burn rate disclosed in the updated financials.

For a portfolio model with $2M total and 10% allocated to IPOs, a $200K single position represents 50% concentration within the IPO sleeve. Pricing is expected in early September 2026. Liquidity planning should account for locked capital until March 2027 at minimum.

Scenario Analysis

Portfolio Size	IPO Allocation Example	Lock-Up Illiquidity Period	Unrealized Loss at Reversal	Remaining Liquid Assets
$500K	$50K example	180 days	$11K at 22% decline	$439K
$1M	$100K example	180 days	$22K at 22% decline	$878K
$2M	$200K example	180 days	$44K at 22% decline	$1.756M

These scenarios illustrate illiquidity impact under a hypothetical 22% price reversal. Actual IPO performance varies significantly by company, sector, and market conditions. Consult your financial advisor before sizing any IPO allocation.

Why This Filing Size Matters

Amended S-1 filings over 25 MB typically contain one or more of the following: restated financials following a pre-IPO acquisition, expanded risk factor disclosures after SEC comment letters, or revised valuation methodology. Non Invasive Monitoring Systems operates in a sector where reimbursement risk, FDA pathway clarity, and Medicare coverage assumptions drive valuation significantly.

If the amendment includes updated clinical trial timelines or Centers for Medicare and Medicaid Services coverage language, the IPO price range could shift materially from initial guidance. The filing date of August 20, 2026 places pricing in the September 8 to September 18 window under standard SEC review timelines, approximately 19 to 29 days ahead. Institutional investors typically receive allocation commitments 48 hours before pricing, creating a three-week evaluation window.

Frequently Asked Questions

Q: What is the typical lock-up period for healthcare IPOs under $500M market cap? A: Lock-up periods typically range from 90 to 180 days post-pricing. Early release provisions vary by deal structure. Consult your underwriter or legal advisor for specific terms.

Q: What allocation levels do HNW investors typically consider for IPO positions? A: Many investors model scenarios with 5% to 10% maximum allocation for any single name and keep total portfolio IPO exposure under 20% when lock-up restrictions apply. Individual circumstances vary based on liquidity profile and risk tolerance. This is not a recommendation; consult your advisor.

Q: When does an amended S-1 filing typically lead to pricing? A: Historical timelines suggest 14 to 21 days post-amendment is a common window, though ranges can extend from 10 to 28 days depending on SEC commentary and market conditions.

Q: What is the downside risk if this IPO prices at $15 and trades at a 22% reversal? A: As an illustrative example, a $100K allocation at $15 per share could decline to $78K at a 22% reversal, representing a $22K unrealized loss. Actual outcomes depend on market conditions and company performance.

Run the Numbers

Use CalcMoney's Calculate Your After-Tax RSU Proceeds to model IPO allocation scenarios on your total liquidity profile through Q1 2027 under multiple price scenarios.

Disclosure: This article is for informational purposes only and does not constitute professional financial advice. IPO investments carry significant risk, including illiquidity risk during lock-up periods. Consult a qualified financial advisor before making any IPO allocation or portfolio management decisions.

Run the Numbers: Capital Gains Tax Terminal on CalcMoney — model your exact figures under current market conditions.

Data sourced from SEC EDGAR S-1 Filings (IPO). Rates and thresholds are for informational purposes only. Consult a licensed financial advisor before making investment or tax decisions.

Featured Partner

FIDELITY